2007
DOI: 10.1016/j.colsurfb.2007.03.004
|View full text |Cite
|
Sign up to set email alerts
|

Fabrication of ultrathin polyelectrolyte fibers and their controlled release properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
63
0
1

Year Published

2008
2008
2019
2019

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 104 publications
(65 citation statements)
references
References 64 publications
0
63
0
1
Order By: Relevance
“…In contrast, at elevated temperatures (70 1C) the swelling degree of the fibers reduced from 15 to 2.6-fold. Chunder et al 118 fabricated PAA/PAH electrospun fibers and incorporated methylene blue (MB), a low molecular weight cationic molecule, as a model drug to evaluate release from the fibers. As PAA and PAH are both weak polyelectrolytes, the release of MB could be triggered by adjusting the pH of the medium.…”
Section: Multi Stimuli-responsive Electrospun Fiber Systemsmentioning
confidence: 99%
“…In contrast, at elevated temperatures (70 1C) the swelling degree of the fibers reduced from 15 to 2.6-fold. Chunder et al 118 fabricated PAA/PAH electrospun fibers and incorporated methylene blue (MB), a low molecular weight cationic molecule, as a model drug to evaluate release from the fibers. As PAA and PAH are both weak polyelectrolytes, the release of MB could be triggered by adjusting the pH of the medium.…”
Section: Multi Stimuli-responsive Electrospun Fiber Systemsmentioning
confidence: 99%
“…A sustained and a temperature controlled drug releasing in PBS solutions was achieved by depositing perfluorosilane coatings and PAA/PNIPAAM multilayers onto the fiber surfaces, respectively. [44] In theory, comprehension and clarification of the relationship between the release profiles and the electrospinning parameters help to select suitable materials, optimize electrospinning process, and thus to improve the consistence between design and manufacturing, reduce the time to market for novel DDS. Since the physical form of the active agent in a dosage form can influence the product performance, it is often necessary to quantify the different solid phases in a system for preparing a robust dosage form.…”
Section: Some Challenges and The Possible Resolutionsmentioning
confidence: 99%
“…Blends of PNIPAM with such biocompatible and biodegradable polymers as Poly(acrylic acid) (PAA) can be easily prepared, which yield PAA polymer matrixes with PNIPAM islands inside. Electrospinning, co-electrospinning and various solution-precipitation methods allow for manufacturing of nanofibers and nanoparticles with embedded or grafted macromolecules [1][2][3][4][5]. In addition, nanofibers and nanoparticles functionalized with drugs attract significant interest in biomedical applications [6], where PNIPAM-like stimuli-responsive materials embedded in the bulk or grafted at the surface may facilitate efficient drug delivery systems.…”
Section: Introductionmentioning
confidence: 99%